Skip to main content
Log in

Steady-state concentration of cotinine as a measure of nicotine-intake by smokers

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Measurement of plasma cotinine, the major metabolite of nicotine, is usually done to determine nicotine-intake in smokers. Cotinine is used instead of nicotine because it has a much longer half-life than the mother substance and its plasma concentrations are therefore less dependent on the exact times of blood sampling. However, the linearity of the relationship between nicotine-intake and cotinine level in plasma has never been proven. Therefore cotinine was measured in 6 healthy volunteers infused over 4 days with several doses of nicotine i.v. up to 480 µg/kg/day. Cotinine concentrations in plasma were shown to be linearly and directly related to nicotine intake. The concentration of cotinine showed little variation during and for up to 2 h after the last dose of nicotine. Therefore, cotinine can be used as an epidemiological marker of nicotine intake if it is measured around the time of the last cigarette of the day.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Benowitz NL, Hall SM, Herning RI, Jacob III P, Jones RT, Osman AL (1983) Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 309: 139–142

    Google Scholar 

  2. Beckett AH, Gorrod JW, Jenner P (1971) The effect of smoking on nicotine metabolism in vivo in man. J Pharmacol 23 [Suppl]: 62S-67S

    Google Scholar 

  3. Rosenberg J, Benowitz NL, Jacob P, Wilson KM (1980) Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 28: 517–522

    Google Scholar 

  4. Benowitz NL, Knyt F, Jacob III P, Jones RT, Osman AL (1983) Cotinine disposition and effects. Clin Pharmacol Ther 34: 604–611

    Google Scholar 

  5. Gori GB, Lynch CL (1983) Smoker intake from cigarettes in the l-mg Federal Trade Commission tar class. Regulat Toxicol Pharmacol 110–120

  6. Gritz ER, Baer-Weiss V, Benowitz NL, Van Vunakis H, Jarvik ME (1981) Plasma nicotine and cotinine concentrations in habituel smokeless users. Clin Pharmacol Ther 30: 201–209

    Google Scholar 

  7. Matsukura S, Sakamoto N, Seino Y, Tamada T, Matsuyama H, Muranaka H (1979) Cotinine excretion and daily cigarette smoking in habituated smokers. Clin Pharmacol Ther 25: 555–561

    Google Scholar 

  8. Beckett AH, Gorrod JW, Jenner P (1972) As possible relation between pKa1 and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man. J Pharmacol 24: 115–120

    Google Scholar 

  9. Benowitz NL, Jacob III P (1984) Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 35: 499–504

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galeazzi, R.L., Daenens, P. & Gugger, M. Steady-state concentration of cotinine as a measure of nicotine-intake by smokers. Eur J Clin Pharmacol 28, 301–304 (1985). https://doi.org/10.1007/BF00543327

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543327

Key words

Navigation